MedPath

Evaluation treatment with biologicals in severe asthma

Recruiting
Conditions
severe asthma, biological
Registration Number
NL-OMON24843
Lead Sponsor
Medical Centre Leeuwarden
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

Patients with severe asthma treated with biologicals

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient characteristics / biomarkers as predictors of response in treatment with biologicals in severe asthma
Secondary Outcome Measures
NameTimeMethod
- The relation between the most useful parameters in response evaluation and the different biologicals / patient characteristics. <br /><br>- The time to respons; the most appropriate time for respons evaluation, relation with patient characteristics (early and late responders), differences between the biologicals and response parameters. <br /><br>- The outcome of treatment with biologicals on medium and longterm in severe asthma.<br /><br>- The effect of treatment with biologicals on ENT-symptoms; parameters as predictors of response. <br>
© Copyright 2025. All Rights Reserved by MedPath